Paul Friedman

Paul Friedman

Chairman at PRELUDE THERAPEUTICS INCORPORATED

Net worth: 255 M $ as of 30/03/2024

81 year
Health Technology
Consumer Services
Commercial Services

Paul Friedman active positions

CompaniesPositionStartEnd
MADRIGAL PHARMACEUTICALS, INC. Director/Board Member 14/06/2023 -
Chief Executive Officer 21/07/2016 10/09/2023
Chairman 21/07/2016 14/06/2023
President 21/07/2016 10/09/2023
PRELUDE THERAPEUTICS INCORPORATED Independent Dir/Board Member - -
Chairman - -
Director/Board Member 30/06/2016 -
Corporate Officer/Principal 28/05/2009 -
American Society for Pharmacology & Experimental Therapeutic Corporate Officer/Principal 28/05/2009 -
Corporate Officer/Principal - -

Career history of Paul Friedman

Former positions of Paul Friedman

CompaniesPositionStartEnd
ALEXION PHARMACEUTICALS, INC. Director/Board Member 13/09/2017 13/07/2021
Independent Dir/Board Member 13/09/2017 13/07/2021
INCYTE CORPORATION Director/Board Member 31/10/2001 25/05/2021
Chief Executive Officer 31/10/2001 12/11/2014
Independent Dir/Board Member 12/11/2014 25/05/2021
President 30/04/2004 12/11/2014
VERASTEM, INC. Director/Board Member 11/05/2014 26/04/2017
Independent Dir/Board Member 13/04/2015 26/04/2017
Director/Board Member 29/06/2016 01/01/2017
Chairman 28/10/2014 29/06/2016
Independent Dir/Board Member 31/12/2013 28/10/2014
░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░ ░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ -
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ -
░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ - -
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ -

Training of Paul Friedman

Princeton University Undergraduate Degree
Harvard Medical School Doctorate Degree

Statistics

International

United States 22

Operational

Director/Board Member 13
Independent Dir/Board Member 9
Corporate Officer/Principal 5

Sectoral

Health Technology 17
Consumer Services 3
Commercial Services 2

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies4
INCYTE CORPORATION

Health Technology

VERASTEM, INC.

Health Technology

PRELUDE THERAPEUTICS INCORPORATED

Health Technology

MADRIGAL PHARMACEUTICALS, INC.

Health Technology

Private companies15

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

American Society for Pharmacology & Experimental Therapeutic

DuPont Pharmaceuticals Research Laboratories

Health Technology

See company connections